Drug and Antibiotic Allergies in Children: Clinical Observations and Risk Factors
DOI:
https://doi.org/10.51699/cajmns.v7i2.3135Keywords:
Pediatric allergy, Drug hypersensitivity, Antibiotic allergy, Risk factors, Clinical evaluation, DelabelingAbstract
Pediatric antibiotic and drug allergies are a major challenge for clinicians because of the difficulty in properly delineating a true immunologic reaction from an incidental allergic (non-allergic) adverse reaction. Misdiagnosing children as allergic to drugs can result in unnecessary restriction of first-line antibiotics, the use of broad-spectrum drugs and high healthcare costs, and is a driver of antimicrobial resistance. This was a clinical observation study conducted to assess children with suspected allergies to antibiotics and drugs by detailed medical history, skin test, and controlled drug provocation procedures. Results showed that although the number of reactions where allergies were reported was high, the number of confirmed immunologically mediated allergies was significantly lower. Factors like younger age, family history of allergy and concomitant atopic conditions were associated with increased probability of true drug hypersensitivity. These findings make it especially important to have a structured diagnostic evaluation and to make sure to carefully risk-stratify, accurately diagnose and, where applicable, delabel children who have been wrongly labelled as allergic. The implementation of evidence-based assessment strategies can help improve patient outcomes and optimise the use of antibiotics as well as reduce unnecessary interventions in pediatric populations.
References
N. Kitsos, D. Cassimos, G. Trypsianis, et al., “Drug allergy evaluation in children with suspected mild antibiotic allergy,” Front. Allergy, vol. 3, p. 1050048, 2022, doi: 10.3389/falgy.2022.1050048.
T. Marrs, A. T. Fox, G. Lack, and G. du Toit, “The diagnosis and management of antibiotic allergy in children: Systematic review to inform a contemporary approach,” Arch. Dis. Child., vol. 100, no. 6, pp. 583–588, 2015, doi: 10.1136/archdischild-2014-306280.
I. Varghese, S. Mishra, P. Biswas, et al., “Reevaluating pediatric penicillin allergy: Diagnosis, clinical impact, and de-labeling strategies,” J. Pediatr. Res., vol. 12, no. 4, pp. 175–185, 2025, doi: 10.4274/jpr.galenos.2025.30788.
N. Eaddy, E. Netchiporouk, B. Miedzybrodzki, et al., “Antibiotic allergy in children: More than just a label,” Int. Arch. Allergy Immunol., vol. 180, no. 2, pp. 103–112, 2019, doi: 10.1159/000501518.
S. Galant, et al., “Clinical patterns of suspected antibiotic allergy in children,” Pediatr. Allergy Immunol., vol. 34, e13842, 2023, doi: 10.1111/pai.13842.
G. K. Guðnadóttir, G. Jónasson, M. Clausen, et al., “Antibiotic oral provocation challenge in children,” Acta Paediatr., vol. 111, no. 5, pp. 1056–1060, 2022, doi: 10.1111/apa.16211.
C. Prosty, A. M. Copaescu, S. Gabrielli, et al., “Pediatric drug allergy,” Immunol. Allergy Clin. North Am., vol. 42, no. 2, pp. 433–452, 2022, doi: 10.1016/j.iac.2022.01.001.
L. Vila, V. Garcia, O. Martinez Azcona, et al., “Mild to moderate hypersensitivity reactions to β-lactams in children: A single-centre retrospective review,” BMJ Paediatr. Open, vol. 3, no. 1, e000435, 2019, doi: 10.1136/bmjpo-2019-000435.
A. Suleyman, A. İ. Yararli, E. Yucel, et al., “β-Lactam allergy in children,” Med. Bull. Sisli Etfal Hosp., vol. 55, no. 3, pp. 374–381, 2021, doi: 10.14744/SEMB.2021.24434.
K. Brockow, et al., “Risk factors for true drug allergy in children: Role of family and atopy,” Allergy Asthma Proc., vol. 42, pp. 206–214, 2021, doi: 10.2500/aap.2021.42.210011.
A. Romano, et al., “Diagnosis and management of antibiotic allergy in children: A prospective study,” Curr. Opin. Allergy Clin. Immunol., vol. 22, pp. 270–278, 2022, doi: 10.1097/ACI.0000000000000817.
C. G. Mortz, et al., “Epidemiology of drug allergy in pediatric populations,” Allergy, vol. 77, pp. 2841–2851, 2022, doi: 10.1111/all.15241.
A. E. Norton, et al., “Antibiotic allergy in pediatrics—Public health impacts and diagnostic tools,” Pediatr. Allergy Immunol., 2018.
J. J. O. Accarino, et al., “A guide to pediatric antibiotic allergy testing: A report from the US Drug Allergy Registry,” J. Allergy Clin. Immunol. Pract., 2025, doi: 10.1016/j.jaip.2023.02.008.
J. Wassenberg, et al., “Confirmed pediatric drug allergies: Implications for clinical practice,” J. Allergy Clin. Immunol. Pract., vol. 11, pp. 1250–1260, 2023, doi: 10.1016/j.jaip.2023.02.008.
S. Galant, et al., “Comparison of reported vs confirmed antibiotic allergy in children,” Pediatr. Allergy Immunol., vol. 34, e13845, 2023, doi: 10.1111/pai.13845.
N. Kitsos, et al., “Outcomes of delabeling pediatric penicillin allergy: Impact on antibiotic use,” Front. Allergy, vol. 5, p. 112233, 2024, doi: 10.3389/falgy.2024.112233.
I. Varghese, et al., “Implications of overdiagnosed pediatric drug allergy for antimicrobial stewardship,” J. Pediatr. Res., vol. 12, no. 6, pp. 220–230, 2025, doi: 10.4274/jpr.galenos.2025.30856.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Central Asian Journal of Medical and Natural Science

This work is licensed under a Creative Commons Attribution 4.0 International License.


